Lipoxins A4 and B4 inhibit glial cell activation via CXCR3 signaling in acute retinal neuroinflammation

Abstract Lipoxins are small lipids that are potent endogenous mediators of systemic inflammation resolution in a variety of diseases. We previously reported that Lipoxins A4 and B4 (LXA4 and LXB4) have protective activities against neurodegenerative injury. Yet, lipoxin activities and downstream sig...

Full description

Bibliographic Details
Main Authors: Izhar Livne-Bar, Shubham Maurya, Karsten Gronert, Jeremy M. Sivak
Format: Article
Language:English
Published: BMC 2024-01-01
Series:Journal of Neuroinflammation
Subjects:
Online Access:https://doi.org/10.1186/s12974-024-03010-0
_version_ 1797355649397424128
author Izhar Livne-Bar
Shubham Maurya
Karsten Gronert
Jeremy M. Sivak
author_facet Izhar Livne-Bar
Shubham Maurya
Karsten Gronert
Jeremy M. Sivak
author_sort Izhar Livne-Bar
collection DOAJ
description Abstract Lipoxins are small lipids that are potent endogenous mediators of systemic inflammation resolution in a variety of diseases. We previously reported that Lipoxins A4 and B4 (LXA4 and LXB4) have protective activities against neurodegenerative injury. Yet, lipoxin activities and downstream signaling in neuroinflammatory processes are not well understood. Here, we utilized a model of posterior uveitis induced by lipopolysaccharide endotoxin (LPS), which results in rapid retinal neuroinflammation primarily characterized by activation of resident macroglia (astrocytes and Müller glia), and microglia. Using this model, we observed that each lipoxin reduces acute inner retinal inflammation by affecting endogenous glial responses in a cascading sequence beginning with astrocytes and then microglia, depending on the timing of exposure; prophylactic or therapeutic. Subsequent analyses of retinal cytokines and chemokines revealed inhibition of both CXCL9 (MIG) and CXCL10 (IP10) by each lipoxin, compared to controls, following LPS injection. CXCL9 and CXCL10 are common ligands for the CXCR3 chemokine receptor, which is prominently expressed in inner retinal astrocytes and ganglion cells. We found that CXCR3 inhibition reduces LPS-induced neuroinflammation, while CXCR3 agonism alone induces astrocyte reactivity. Together, these data uncover a novel lipoxin–CXCR3 pathway to promote distinct anti-inflammatory and proresolution cascades in endogenous retinal glia.
first_indexed 2024-03-08T14:14:11Z
format Article
id doaj.art-6dbf4018fefc4d41be13e85194369231
institution Directory Open Access Journal
issn 1742-2094
language English
last_indexed 2024-03-08T14:14:11Z
publishDate 2024-01-01
publisher BMC
record_format Article
series Journal of Neuroinflammation
spelling doaj.art-6dbf4018fefc4d41be13e851943692312024-01-14T12:30:45ZengBMCJournal of Neuroinflammation1742-20942024-01-0121111310.1186/s12974-024-03010-0Lipoxins A4 and B4 inhibit glial cell activation via CXCR3 signaling in acute retinal neuroinflammationIzhar Livne-Bar0Shubham Maurya1Karsten Gronert2Jeremy M. Sivak3Department of Vision Sciences, Donald K Johnson Eye Institute, Krembil Research Institute, University Health NetworkHerbert Wertheim School of Optometry and Vision Science, University of California BerkeleyHerbert Wertheim School of Optometry and Vision Science, University of California BerkeleyDepartment of Vision Sciences, Donald K Johnson Eye Institute, Krembil Research Institute, University Health NetworkAbstract Lipoxins are small lipids that are potent endogenous mediators of systemic inflammation resolution in a variety of diseases. We previously reported that Lipoxins A4 and B4 (LXA4 and LXB4) have protective activities against neurodegenerative injury. Yet, lipoxin activities and downstream signaling in neuroinflammatory processes are not well understood. Here, we utilized a model of posterior uveitis induced by lipopolysaccharide endotoxin (LPS), which results in rapid retinal neuroinflammation primarily characterized by activation of resident macroglia (astrocytes and Müller glia), and microglia. Using this model, we observed that each lipoxin reduces acute inner retinal inflammation by affecting endogenous glial responses in a cascading sequence beginning with astrocytes and then microglia, depending on the timing of exposure; prophylactic or therapeutic. Subsequent analyses of retinal cytokines and chemokines revealed inhibition of both CXCL9 (MIG) and CXCL10 (IP10) by each lipoxin, compared to controls, following LPS injection. CXCL9 and CXCL10 are common ligands for the CXCR3 chemokine receptor, which is prominently expressed in inner retinal astrocytes and ganglion cells. We found that CXCR3 inhibition reduces LPS-induced neuroinflammation, while CXCR3 agonism alone induces astrocyte reactivity. Together, these data uncover a novel lipoxin–CXCR3 pathway to promote distinct anti-inflammatory and proresolution cascades in endogenous retinal glia.https://doi.org/10.1186/s12974-024-03010-0LipoxinsRetinaUveitisNeuroinflammationInflammation resolutionGliosis
spellingShingle Izhar Livne-Bar
Shubham Maurya
Karsten Gronert
Jeremy M. Sivak
Lipoxins A4 and B4 inhibit glial cell activation via CXCR3 signaling in acute retinal neuroinflammation
Journal of Neuroinflammation
Lipoxins
Retina
Uveitis
Neuroinflammation
Inflammation resolution
Gliosis
title Lipoxins A4 and B4 inhibit glial cell activation via CXCR3 signaling in acute retinal neuroinflammation
title_full Lipoxins A4 and B4 inhibit glial cell activation via CXCR3 signaling in acute retinal neuroinflammation
title_fullStr Lipoxins A4 and B4 inhibit glial cell activation via CXCR3 signaling in acute retinal neuroinflammation
title_full_unstemmed Lipoxins A4 and B4 inhibit glial cell activation via CXCR3 signaling in acute retinal neuroinflammation
title_short Lipoxins A4 and B4 inhibit glial cell activation via CXCR3 signaling in acute retinal neuroinflammation
title_sort lipoxins a4 and b4 inhibit glial cell activation via cxcr3 signaling in acute retinal neuroinflammation
topic Lipoxins
Retina
Uveitis
Neuroinflammation
Inflammation resolution
Gliosis
url https://doi.org/10.1186/s12974-024-03010-0
work_keys_str_mv AT izharlivnebar lipoxinsa4andb4inhibitglialcellactivationviacxcr3signalinginacuteretinalneuroinflammation
AT shubhammaurya lipoxinsa4andb4inhibitglialcellactivationviacxcr3signalinginacuteretinalneuroinflammation
AT karstengronert lipoxinsa4andb4inhibitglialcellactivationviacxcr3signalinginacuteretinalneuroinflammation
AT jeremymsivak lipoxinsa4andb4inhibitglialcellactivationviacxcr3signalinginacuteretinalneuroinflammation